ID: ALA5272399

Max Phase: Preclinical

Molecular Formula: C2H4BrO4P

Molecular Weight: 202.93

Associated Items:

Representations

Canonical SMILES:  O=C(CBr)P(=O)(O)O

Standard InChI:  InChI=1S/C2H4BrO4P/c3-1-2(4)8(5,6)7/h1H2,(H2,5,6,7)

Standard InChI Key:  SIPHYBMYOWLBOA-UHFFFAOYSA-N

Associated Targets(Human)

GAPDH Tchem Glyceraldehyde-3-phosphate dehydrogenase liver (1284 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 202.93Molecular Weight (Monoisotopic): 201.9031AlogP: 0.09#Rotatable Bonds: 2
Polar Surface Area: 74.60Molecular Species: ACIDHBA: 2HBD: 2
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 0.53CX Basic pKa: CX LogP: -0.68CX LogD: -4.54
Aromatic Rings: 0Heavy Atoms: 8QED Weighted: 0.49Np Likeness Score: 0.36

References

1. Galbiati A, Zana A, Conti P..  (2020)  Covalent inhibitors of GAPDH: From unspecific warheads to selective compounds.,  207  [PMID:32898762] [10.1016/j.ejmech.2020.112740]

Source